These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis. Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522 [TBL] [Abstract][Full Text] [Related]
4. Prescribing antipsychotic medications to people with dementia. Croucher M N Z Med J; 2011 Apr; 124(1333):68. PubMed ID: 21750587 [No Abstract] [Full Text] [Related]
5. [Thioridazine and the warning about prolonged QT time]. Laisalmi M Duodecim; 2002; 118(24):2518. PubMed ID: 12572286 [No Abstract] [Full Text] [Related]
6. [How long should prophylactic antipsychotic therapy last after the initial schizophrenic psychosis?]. Vlaminck P Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2160-1. PubMed ID: 9856234 [No Abstract] [Full Text] [Related]
7. Restricting the use of thioridazine. Bailey P; Russell V Br J Gen Pract; 2002 Jun; 52(479):499-500. PubMed ID: 12051223 [No Abstract] [Full Text] [Related]
8. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort. Purhonen M; Koponen H; Tiihonen J; Tanskanen A Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581 [TBL] [Abstract][Full Text] [Related]
9. A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis. Lofft JG; Demars JP Dis Nerv Syst; 1974 Sep; 35(9):409-15. PubMed ID: 17894066 [No Abstract] [Full Text] [Related]
10. [The decision of the pharmacologic authority--the doubts of a clinician]. Kovács G Neuropsychopharmacol Hung; 2009 Mar; 11(1):1-2. PubMed ID: 19731812 [No Abstract] [Full Text] [Related]
11. [Treatment of acute schizophrenia with sulforidazine]. Sánchez E; Ning JL; Núñez H; Medina E Rev Neuropsiquiatr; 1975 Jun; 38(2):94-105. PubMed ID: 1839 [No Abstract] [Full Text] [Related]
12. Re: Thioridazine: re-evaluating the risk/benefit equation. Timell AM Ann Clin Psychiatry; 2003 Jun; 15(2):131. PubMed ID: 12938870 [No Abstract] [Full Text] [Related]
13. Concomitant use of antipsychotics with risperidone. Chouinard G Am J Health Syst Pharm; 1996 Feb; 53(4):443. PubMed ID: 8673669 [No Abstract] [Full Text] [Related]
15. Phenothiazine poisoning. A review of 48 cases. Barry D; Meyskens FL; Becker CE Calif Med; 1973 Jan; 118(1):1-5. PubMed ID: 4405537 [TBL] [Abstract][Full Text] [Related]
16. Prescribing patterns in schizophrenic inpatients in Trinidad and Tobago. Jaime LK; Ramtahal I; Maharajh H; Moore S; Ramsewak F Pharmacoepidemiol Drug Saf; 2002; 11(5):415-6. PubMed ID: 12271885 [No Abstract] [Full Text] [Related]
17. Cardiotoxicity and prescription of thioridazine in New Zealand. Menkes DB; Knight JC Aust N Z J Psychiatry; 2002 Aug; 36(4):492-8. PubMed ID: 12169148 [TBL] [Abstract][Full Text] [Related]
18. Prolactin response to neuroleptics. Clinical and theoretical implications. Ohman R; Axelsson R J Neural Transm Suppl; 1980; 17():1-74. PubMed ID: 6133911 [No Abstract] [Full Text] [Related]
19. Real-world antipsychotic treatment practices. Moore TA; Covell NH; Essock SM; Miller AL Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029 [TBL] [Abstract][Full Text] [Related]
20. Intracorporeal phenylephrine reduces thioridazine (Mellaril) induced priapism in a child. Siegel JF; Reda E J Urol; 1997 Feb; 157(2):648. PubMed ID: 8996390 [No Abstract] [Full Text] [Related] [Next] [New Search]